Female Desire: What You Should Know Before Reaching for the Pink Pill

Female Desire: What You Should Know Before Reaching for the Pink Pill
The approval of Addyi, the first ever pharmaceutical for low libido in women, comes with much debate. AP Photo/Allen G. Breed
June Kellum
Updated:

Desire depends on complex, dynamic factors, and low libido in women can often be the proverbial tip of the iceberg—the symptom that’s most noticeable, but only a small piece of the whole issue. 

Addyi (flibanserin), known as the “pink pill,” is the first-ever FDA-approved pharmaceutical for female libido. Although it’s been hailed the female version of Viagra, that comparison is not really apt: Viagra relaxes muscles and increases blood flow, whereas Addyi—which was developed from an antidepressant—acts solely on brain chemicals and is supposed to be taken daily rather than only when intimacy is wanted.

June Kellum
June Kellum
Author
June Kellum is a married mother of three and longtime Epoch Times journalist covering family, relationships, and health topics.
Related Topics